EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Psoriatic Arthritis: From Diagnosis to Treatment

Renuka Kannappan iD, Sarah Kim iD, Arthur Lau, Lawrence H Brent

Journal of Clinical Medicine · 17.11.2025 · 14 (22) · 8151

DOI: 10.3390/jcm14228151 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.11.2025. Verfasst von Renuka Kannappan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Temple University Hospital, Philadelphia, PA 19140, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriatic arthritis (PsA) is a chronic, immune-mediated inflammatory arthritis associated with psoriasis, affecting joints, entheses, and the axial skeleton. While primary care providers and dermatologists frequently encounter psoriasis (PsO), early recognition of PsA remains critical to preventing irreversible joint damage. This paper is written to provide a comprehensive overview of PsA, beginning with a clinical case that highlights diagnostic and therapeutic challenges. In this review, the epidemiology of PsA will be discussed, emphasizing its prevalence and risk factors among patients with PsO. The discussion extends to the underlying pathogenesis, focusing on genetic predisposition, environmental triggers, and key cytokines, including TNF-α, IL-17, and IL-23, that have become targets for advanced therapeutics. The clinical features of PsA are explored in detail, including peripheral and axial arthritis, enthesitis, dactylitis, and extra-articular manifestations. Diagnostic approaches are discussed, with a focus on the Classification Criteria for Psoriatic Arthritis (CASPAR) and Moll & Wright criteria. Additionally, we examine screening tools designed to facilitate early detection in dermatology clinics. Diagnostic modalities, including imaging and serologic markers, are reviewed. Finally, we explore the evolving landscape of PsA treatment, spanning conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), biologic agents (bDMARDs), and targeted synthetic DMARDs (tsDMARDs). Given the increasing availability of cytokine-targeted therapies, an interdisciplinary approach between dermatologists and rheumatologists is essential for optimizing outcomes in PsA patients. Patients with PsA are cared for by rheumatologists, dermatologists, and primary care providers who help manage the comorbidities associated with PsA. By bridging primary care, dermatology, and rheumatology in the care of PsA, this paper aims to enhance understanding of PsA for facilitating early identification and timely intervention for improved patient care.

Schlagwörter

Stichwörter der Autor:innen

DMARDsimagingpreventionpsoriasispsoriatic arthritisultrasound

Autor:innen und Institutionen

  • Department of Internal Medicine, Temple University Hospital, Philadelphia, PA 19140, USA.
  • Department of Rheumatology, Jefferson-Einstein Hospital, Philadelphia, PA 19141, USA.
  • Department of Rheumatology, Temple University Hospital, Philadelphia, PA 19140, USA.

ORCID-Profile: Renuka Kannappan, Sarah Kim

Zitieren

APA

Kannappan, R., Kim, S., Lau, A., & Brent, L. H. (2025). Psoriatic Arthritis: From Diagnosis to Treatment. Journal of Clinical Medicine, 14(22), 8151. https://doi.org/10.3390/jcm14228151

Vancouver

Kannappan R, Kim S, Lau A, Brent LH. Psoriatic Arthritis: From Diagnosis to Treatment. Journal of Clinical Medicine. 2025;14(22):8151. doi:10.3390/jcm14228151

BibTeX
@article{Kannappan2025,
  author = {Kannappan, Renuka and Kim, Sarah and Lau, Arthur and Brent, Lawrence H},
  title = {Psoriatic Arthritis: From Diagnosis to Treatment},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {22},
  pages = {8151},
  doi = {10.3390/jcm14228151}
}
Kostenlos starten →